These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

150 related items for PubMed ID: 2138566

  • 1. Idebenone attenuates neuronal degeneration induced by intrastriatal injection of excitotoxins.
    Miyamoto M, Coyle JT.
    Exp Neurol; 1990 Apr; 108(1):38-45. PubMed ID: 2138566
    [Abstract] [Full Text] [Related]

  • 2. Peripheral type benzodiazepine binding sites are a sensitive indirect index of neuronal damage.
    Benavides J, Fage D, Carter C, Scatton B.
    Brain Res; 1987 Sep 22; 421(1-2):167-72. PubMed ID: 2891401
    [Abstract] [Full Text] [Related]

  • 3. Prolonged infusion of quinolinic acid into rat striatum as an excitotoxic model of neurodegenerative disease.
    Susel Z, Engber TM, Kuo S, Chase TN.
    Neurosci Lett; 1991 Jan 02; 121(1-2):234-8. PubMed ID: 1826944
    [Abstract] [Full Text] [Related]

  • 4. Differential sparing of somatostatin-neuropeptide Y and cholinergic neurons following striatal excitotoxin lesions.
    Beal MF, Kowall NW, Swartz KJ, Ferrante RJ, Martin JB.
    Synapse; 1989 Jan 02; 3(1):38-47. PubMed ID: 2563916
    [Abstract] [Full Text] [Related]

  • 5. Neuroprotective effects of MK-801 in vivo: selectivity and evidence for delayed degeneration mediated by NMDA receptor activation.
    Foster AC, Gill R, Woodruff GN.
    J Neurosci; 1988 Dec 02; 8(12):4745-54. PubMed ID: 2904493
    [Abstract] [Full Text] [Related]

  • 6. Immature cortical neurons are uniquely sensitive to glutamate toxicity by inhibition of cystine uptake.
    Murphy TH, Schnaar RL, Coyle JT.
    FASEB J; 1990 Apr 01; 4(6):1624-33. PubMed ID: 2180770
    [Abstract] [Full Text] [Related]

  • 7. Administration of recombinant human Activin-A has powerful neurotrophic effects on select striatal phenotypes in the quinolinic acid lesion model of Huntington's disease.
    Hughes PE, Alexi T, Williams CE, Clark RG, Gluckman PD.
    Neuroscience; 1999 Apr 01; 92(1):197-209. PubMed ID: 10392842
    [Abstract] [Full Text] [Related]

  • 8. The response of striatal neuropeptide Y and cholinergic neurons to excitatory amino acid agonists.
    Boegman RJ, Parent A.
    Brain Res; 1988 Jun 14; 452(1-2):219-26. PubMed ID: 2900050
    [Abstract] [Full Text] [Related]

  • 9. 2,3-Dihydroxy-6-nitro-7-sulfamoyl-benzo(f)quinoxaline protects against both AMPA and kainate-induced lesions in rat striatum in vivo.
    Massieu L, Tapia R.
    Neuroscience; 1994 Apr 14; 59(4):931-8. PubMed ID: 7520137
    [Abstract] [Full Text] [Related]

  • 10. Protective effects of neurotrophin-4/5 and transforming growth factor-alpha on striatal neuronal phenotypic degeneration after excitotoxic lesioning with quinolinic acid.
    Alexi T, Venero JL, Hefti F.
    Neuroscience; 1997 May 14; 78(1):73-86. PubMed ID: 9135090
    [Abstract] [Full Text] [Related]

  • 11. Lamotrigine protects against kainate but not ibotenate lesions in rat striatum.
    McGeer EG, Zhu SG.
    Neurosci Lett; 1990 May 04; 112(2-3):348-51. PubMed ID: 2141673
    [Abstract] [Full Text] [Related]

  • 12. Sparing of cholinergic neurons following quinolinic acid lesions of the rat striatum.
    Davies SW, Roberts PJ.
    Neuroscience; 1988 Aug 04; 26(2):387-93. PubMed ID: 2971892
    [Abstract] [Full Text] [Related]

  • 13. The IGF-I amino-terminal tripeptide glycine-proline-glutamate (GPE) is neuroprotective to striatum in the quinolinic acid lesion animal model of Huntington's disease.
    Alexi T, Hughes PE, van Roon-Mom WM, Faull RL, Williams CE, Clark RG, Gluckman PD.
    Exp Neurol; 1999 Sep 04; 159(1):84-97. PubMed ID: 10486177
    [Abstract] [Full Text] [Related]

  • 14. Tetrahydroaminoacridine potentiates neurotoxicity of quinolinic acid in rat striatum.
    Zhu SG, McGeer EG, Singh EA, McGeer PL.
    Neurosci Lett; 1988 Dec 19; 95(1-3):252-6. PubMed ID: 2976129
    [Abstract] [Full Text] [Related]

  • 15. Behavioral evaluation of the anti-excitotoxic properties of MK-801: comparison with neurochemical measurements.
    Susel Z, Engber TM, Chase TN.
    Neurosci Lett; 1989 Sep 25; 104(1-2):125-9. PubMed ID: 2530473
    [Abstract] [Full Text] [Related]

  • 16. A comparative analysis of the neuroprotective properties of competitive and uncompetitive N-methyl-D-aspartate receptor antagonists in vivo: implications for the process of excitotoxic degeneration and its therapy.
    Massieu L, Thedinga KH, McVey M, Fagg GE.
    Neuroscience; 1993 Aug 25; 55(4):883-92. PubMed ID: 7694181
    [Abstract] [Full Text] [Related]

  • 17. No evidence for preservation of somatostatin-containing neurons after intrastriatal injections of quinolinic acid.
    Davies SW, Roberts PJ.
    Nature; 1993 Aug 25; 327(6120):326-9. PubMed ID: 2884569
    [Abstract] [Full Text] [Related]

  • 18. Effect of MK-801, kynurenate, glycine, dextrorphan and 4-acetylpyridine on striatal toxicity of quinolinate.
    Zhu SG, McGeer EG, McGeer PL.
    Brain Res; 1989 Mar 06; 481(2):356-60. PubMed ID: 2524238
    [Abstract] [Full Text] [Related]

  • 19. Neurons containing NADPH-diaphorase are selectively resistant to quinolinate toxicity.
    Koh JY, Peters S, Choi DW.
    Science; 1986 Oct 03; 234(4772):73-6. PubMed ID: 2875522
    [Abstract] [Full Text] [Related]

  • 20. Neurotoxic effects of endogenous materials: quinolinic acid, L-pyroglutamic acid, and thyroid releasing hormone (TRH).
    McGeer EG, Singh E.
    Exp Neurol; 1984 Nov 03; 86(2):410-3. PubMed ID: 6436049
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.